Clinical Trials Browser

OTHER × Non-Muscle Invasive Bladder Neoplasms × Celecoxib × Clear all

NCT02343614 2015-01-22

Celecoxib for the Treatment of Non-muscle Invasive Bladder Cancer

Phase 2 Completed

Non-Muscle Invasive Bladder Neoplasms